ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 27 filers reported holding ODONATE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $19,203,000 | +43.1% | 1,000,139 | +0.1% | 0.32% | -0.3% |
| Q3 2020 | $13,420,000 | -34.1% | 999,256 | +107.7% | 0.32% | -43.6% |
| Q2 2020 | $20,367,000 | +101.5% | 481,027 | +31.4% | 0.57% | +31.7% |
| Q1 2020 | $10,108,000 | -12.7% | 366,085 | +2.6% | 0.44% | -0.5% |
| Q4 2019 | $11,577,000 | +30.9% | 356,752 | +5.0% | 0.44% | -16.9% |
| Q3 2019 | $8,847,000 | -28.9% | 339,892 | +0.2% | 0.53% | -20.9% |
| Q2 2019 | $12,444,000 | +69.9% | 339,156 | +2.4% | 0.66% | +33.0% |
| Q1 2019 | $7,324,000 | +66.8% | 331,240 | +6.2% | 0.50% | +22.2% |
| Q4 2018 | $4,390,000 | -21.9% | 311,790 | +7.7% | 0.41% | +21.4% |
| Q3 2018 | $5,621,000 | -7.9% | 289,608 | +4.8% | 0.34% | -23.4% |
| Q2 2018 | $6,102,000 | +15.1% | 276,368 | +0.7% | 0.44% | -12.9% |
| Q1 2018 | $5,303,000 | -21.6% | 274,544 | -7.7% | 0.50% | -55.3% |
| Q4 2017 | $6,768,000 | – | 297,555 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |